About this trial
This study is investigating the use of transcranial ultrasound stimulation (TUS) on the Pedunculopontine nucleus (PPN) in changing freezing of gait in people with Parkinson's disease. The PPN is noted to be involved in voluntary movements, locomotion, and muscle tone. This will be assessed by patient-reported outcomes and analyzing the gait. The study will also investigate the effects of the stimulation on the PPN and surrounding connectivity by using magnetic resonance imaging (MRI).
Eligibility criteria
Qualifiers
18-90 years of age
Confirmed diagnosis of a movement disorder with Freezing of Gait
Stable dopaminergic medication dose for a minimum of 4 weeks
Disqualifiers
History of stroke or seizure
Comorbid dementia
Scored below 22 on the Montreal Cognitive Assessment (MoCA)
Has intracranial implant(s) or device(s)
Trial design
Treatments tested in this trial
- Excitatory Stimulation
- Inhibitory Stimulation
- Sham
Treatment groups
Sponsors and collaborators
Robert Chen
Lead sponsor
University Health Network, Toronto
Sponsor institution